Related Experiment Video
Updated: Jan 8, 2026

The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
Published on: April 28, 2015
MERS-COV in the Middle East, a one health concept approach
Iman Dandachi1, Waleed Aljabr1,2,3
1Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Abstract:
The MERS-COV virus is a zoonotic coronavirus that emerged in 2012 in KSA and caused viral illness with a case fatality rate up to 35 %. Over a decade later, the virus is still evolving and circulating. The aim of this review is to discuss the current epidemiology of MERS-COV both in humans and animals, during and post the COVID-19 pandemic. We have found that MERS-COV is still evolving in camels with new lineages being detected in Saudi Arabia. Although the number of human cases has decreased, there is a gradual resurgence in the number of cases. Furthermore, many cases are being reported without exposure to camels and/or raw products, nor contact with known human cases. This necessitates global efforts in the surveillance of asymptomatic carriers in the community, role of unknown animal reservoirs in the virus spread if any, as well as extensive genomic surveillance of the virus. This is in order to unveil and assess the genetic changes that the virus is undergoing and their according effect on the viral fitness, tropism, and virulence. These efforts are crucial for potential future pandemic preparedness, understanding the modes of transmission, as well as drug and vaccine development for MERS-COV.
Insights
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) continues to evolve in dromedary camels, with new lineages emerging. Increased human cases, often without clear exposure, highlight the need for global surveillance and genomic studies.
Area of Science:
- Virology
- Epidemiology
- Public Health
Background:
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV), a zoonotic virus, emerged in 2012 with a high fatality rate.
- Despite over a decade, MERS-CoV remains a public health concern, circulating and evolving in animal reservoirs.
- The COVID-19 pandemic context necessitates a re-evaluation of MERS-CoV epidemiology.
Purpose of the Study:
- To review the current epidemiology of MERS-CoV in humans and animals.
- To analyze MERS-CoV's evolution and circulation patterns post-COVID-19 pandemic.
- To identify knowledge gaps and recommend future surveillance strategies.
Main Methods:
- Literature review of MERS-CoV epidemiology.
- Analysis of recent MERS-CoV surveillance data in humans and animals.
- Genomic surveillance data interpretation.
Main Results:
- New MERS-CoV lineages are detected in dromedary camels in Saudi Arabia.
- A gradual resurgence of human MERS-CoV cases is observed.
- An increasing number of cases lack clear exposure to camels, raw products, or known human cases.
Conclusions:
- Ongoing viral evolution in camels poses a continued risk.
- The emergence of cases with unknown transmission routes underscores the need for enhanced global surveillance.
- Genomic surveillance is critical for understanding viral changes, transmission, and developing countermeasures for MERS-CoV.
Related Concept Videos
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Concepts of Health and Illness
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Secondary Healthcare System

